Traceability, witnessing, cryostorage mapping, device monitoring and KPIs — in one system that a working laboratory actually wants to use. Designed on the bench at a functioning IVF centre, not in a product meeting.
Not yet cleared for real patient data — see current status.
So the witnessing step is an afterthought, the cryo map lives in a spreadsheet, the QC binder is paper, and the KPIs arrive three months late — if at all. Meanwhile the embryologist is the one holding it all together, by memory.
Each area of the lab gets its own workspace, but they share one record. Data captured at the bench propagates to inventory, custody, cryo and KPIs without anyone re-typing it.
The lab day, sequenced and prepared.
The complete follow-up file and the paper-free lab sheet.
Where every sample is, and who touched it.
KPIs continuously, not quarterly.
Audit-ready without the binder.
Who sees what, and where the data lives.
There is an intelligence layer, and it is deliberately disciplined. It records, correlates and raises things worth looking at. It does not make clinical decisions, and it is not allowed to confirm a witnessed step on your behalf.
Any piece of data is captured in one place with one schema, then propagated wherever it's needed. No double entry, no second copy drifting out of sync.
The system proposes; a qualified operator confirms. Clinical judgements and witnessed steps are always confirm-first — that's architectural, not a setting.
Every module writes witnessing events into a single unified chain of custody. There is never a second, competing record for an inspector to reconcile.
Outcome correlations are observed, not controlled — confounded by case mix, operator, incubator and era. The system labels them that way, in the interface, every time.
No ranking or "optimum" is shown below a real threshold. Sub-threshold data is still displayed, but marked ineligible rather than quietly excluded.
Built with a self-hosted, on-premises option in mind so clinics with data-residency obligations can keep patient data inside their own jurisdiction.
Append-only is not the same as tamper-proof. A browser cannot record a true IP address. Risk-adjusted outcome comparison needs a defined case-mix methodology before it means anything — so those features stay gated until it exists, rather than shipping a number that looks authoritative and isn't.
Demonstration data is badged as demonstration data. If a feature is a recording layer without the downstream connection built yet, the interface says so.
"I built the thing I wanted to use at 6am on an OPU day."
Every workflow in the platform was specified by someone who performs it. The witness points are where they actually are. The prep calculator follows the SOP rather than estimating. The grading uses the Istanbul/Gardner convention the lab already writes on the sheet.
Clinical methodology and product direction are shaped together with a co-founding OB-GYN, so the lab-side and clinical-side views of a cycle stay consistent.
This is a real, working system in active daily development — not a finished commercial product. Here is exactly where the line sits.
Nearly forty modules across the six domains, deployed and usable, with a continuously tested core.
Unified custody log with named operator and witness on every witnessed step, written from every module that produces one.
Live KPIs computed from records and benchmarked against published ESHRE competency and aspirational thresholds, each showing its n.
The adapter for on-premises clinic EMR write-back is built and unit-tested; live wiring needs per-clinic credentials and field mappings.
Legal and compliance review has not been completed. The system currently runs on demonstration data, clearly badged as such. Pilot deployments will follow that review.
Comparisons that touch clinical management are gated until the case-mix adjustment methodology is defined. We'd rather show nothing than show something misleading.
If you run or work in an IVF laboratory and any of this sounds like your Tuesday, get in touch. We're talking to a small number of clinics about early access — and we're just as interested in what we've got wrong.